RecallDepth
Class II Terminated

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054

Company
Sandoz Inc
Recall Initiated
August 24, 2016
Posted
November 16, 2016
Recall Number
D-0133-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
42,740 cartons (24 count carton from 7 total lots)
Firm Location
Princeton, NJ, United States

Reason for Recall

Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.

Distribution

TN

Lot / Code Info

NDC 10019-553-02 (24 ct. carton) and NDC 10019-553-88 (patch); Lot #'s FV5908 and FX1520 both with expiry 06/2018; GB4910 and GC4210 both with expiry 09/2018; GE1927 with expiry 12/2018; GF7017 with expiry 01/2019 and GH8065 with expiry 02/2019.

More recalls by Sandoz Inc

View all recalls by this company →

Other recent Class II Drug recalls